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SurgicalSolutions
HIPEC Program Combines Surgery
and Heated Chemotherapy to Treat
Advanced Abdominal Cancers
“That’s the range that scientific research has
shown is optimal for chemotherapeutic drugs
to penetrate and kill any remaining cancer cells,”
says Dr. Bowne. “This regional perfusion enables
us to deliver a much higher concentration of
chemotherapy than a patient could tolerate in
the bloodstream.”
HIPEC is an effective treatment option for
selected patients with appendiceal/PMP cancer
as well as other abdominal conditions, such as
peritoneal mesothelioma and cancer of the colon,
ovaries and stomach.

Over 6 years ago, Mary Johnson was referred to Dr. Wilbur Bowne with a rare and concerning diagnosis—pseudomyxoma peritonei (PMP).

Six years ago, when Mary E. Johnson began
experiencing a change in bowel habits, she didn’t
hesitate to schedule an appointment with her
primary care physician, Katie M. Dougherty, DO.
Now 73, Johnson recalls hoping Dr. Dougherty
would prescribe medication and send her home.
Instead, the physician ordered a battery of tests
that led to a serious and rare (approximately one
in a million) diagnosis: pseudomyxoma peritonei
(PMP), a slow-growing cancer of the appendix.
In 2019, Kathleen Neider, now 66, was suffering
from recurring pains in her abdomen. After
months of pushing through the pain, Neider’s
sister, a nurse, insisted she be seen at the
hospital. After testing by a gastroenterologist,
she, too, was diagnosed with cancer of the
appendix. Neider was initially treated with bowel
surgery followed by a course of chemotherapy.
After a year of remission, follow-up scans
showed cancer recurrence on her ovaries
and near the site of the earlier resection.
Historically, patients with PMP and other
advanced abdominal cancers faced a poor
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prognosis, with treatment largely focused on
alleviating symptoms rather than preventing
disease progression and increasing survival rates.
Johnson and Neider were able to take advantage
of an effective treatment option: cytoreductive
surgery with hyperthermic intraperitoneal
chemotherapy (HIPEC), a newer treatment
available at only a few institutions in the
Delaware Valley.
Both women underwent the procedure with
surgical oncologist Wilbur B. Bowne, MD, who
has been performing this treatment for over a
decade and established the Jefferson HIPEC
Program in January 2020. As Dr. Bowne explains,
HIPEC surgery is a two-part treatment. The first
step is cytoreductive surgery to remove all visible
tumors in the abdominal cavity. The second part
involves administering high doses of heated
chemotherapy to eliminate remaining
microscopic cancer cells. The solution is
circulated throughout the patient’s abdomen
and pelvis for at least 90 minutes at a
temperature of 41 to 43 degrees Celsius (106 to
109 degrees Fahrenheit).
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Dr. Bowne notes that Jefferson’s HIPEC Program
relies on important partnerships and
multidisciplinary collaboration with a range of
specialists, including gynecologic oncology
surgeons, anesthesiologists, surgical oncologists,
urologists, medical oncologists, operating room
staff, and nurse practitioners. Madison Halder, RN,
and clinical coordinator Angela Owens, in
particular, are essential team members who help
patients navigate their pre- and post-op
experience.
HIPEC is a lengthy and complex procedure and
not suitable for every patient (Johnson’s and
Neider’s HIPEC procedures lasted 13 and 10
hours, respectively). Dr. Bowne explains that a
patient typically needs to demonstrate a favorable
treatment response to traditional chemotherapy,
along with sufficient stamina to undergo and
recover from the procedure.
Two months after HIPEC treatment, Neider is still
navigating her recovery and praises Dr. Bowne
and the team for her care.
“Dr. Bowne and his staff have been amazing.
I have called him, and he always takes my calls
and answers my questions. We always decide
together what we’re going to do,” she says.
For Johnson, it’s been over six years since she
met Dr. Bowne and underwent her HIPEC
procedure. She remains “ecstatic” about her
outcome, adding that she takes minimal
medication and is “feeling good.”
“I thank God that the scientific and medical brains
came together to save my life,” Johnson says.
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Overview

New Faculty
Charles J. Yeo, MD, FACS

Seye Adekeye, MD, PhD, has joined the
Division of General Surgery. Dr. Adekeye
completed the General Surgery Residency
Program at the University of North Dakota
followed by a Breast Oncology Fellowship
at the University of Pennsylvania in 2021.
She currently sees patients at the
Jefferson Breast Care Center in Center
City and will soon see patients at
Jefferson Health – Washington Township
in New Jersey.

Samuel D. Gross Professor and Chairman
Department of Surgery
Senior Vice President and Chair, Enterprise Surgery
Jefferson Health

Over 500: A Grim Statistic
I am writing this on the last day of November, 2021. This time of year is
embedded in my mind. Just before my tenth birthday, on Friday, November 22,
1963, our 35th president, JFK, was assassinated in Dallas, TX. Sadness, shock,
tears, and disbelief overtook my classroom. Suddenly, the power of firearms,
and their destructive nature was real to a fifth grader.

Avinoam Nevler, MD, has joined the
Division of General Surgery and Division
of Surgical Research. Dr. Nevler spent 13
years serving as an army physician in the
Israeli military. In 2018, he completed his
surgical residency at Sheba Medical
Center in Israel. During the program he
spent two years as a bench researcher in
the Department of Surgery at Jefferson
and is a 2020 graduate of our Advanced
GI Surgery Fellowship Program. He sees
patients at the Jefferson Pancreas, Biliary,
and Related Cancer Center in Center City.

Fast forward to 2021. The number 500 is a reality in Philadelphia. If you bat
.500 in baseball you are an all-star. If you hit 500 home runs you have a place
in Cooperstown—the Hall of Fame. What if your city exceeds 500 homicides
by firearm? Such is the reality in Philadelphia in 2021. What if a co-worker at
your hospital is one of the victims, shot in your own hospital?
Amidst the COVID pandemic we have another epidemic in America. Death
by firearms. There are nearly 40,000 firearm-related deaths annually in the
U.S. Over 110 victims per day. The U.S. firearm fatality rate has risen in recent
years. The number of guns in America exceeds the number of people. Here
at Jefferson, with the closure of Hahnemann Hospital, we have seen a sharp
up-tick in patients being brought to our emergency room, victims of firearm
violence. Today at the Oxford High School in Michigan a 15-year-old sophomore
killed four fellow students with a handgun, and injured seven others.

Deviney Rattigan, MD, has joined
the Division of Acute Care Surgery.
Dr. Rattigan is a 2014 graduate of
Jefferson Medical College. She then
completed the General Surgery Residency
Program at Cooper University Hospital
followed by the Trauma Surgical Critical
Care Fellowship Program at Rutgers New
Jersey Medical School. She sees patients
at Thomas Jefferson University Hospital
in Center City.

Dr. Stanton Miller and other members of the Jefferson Center for Injury
Research and Prevention (JCIRP) recently participated in a city-wide march
from Amtrak’s 30th Street Station to City Hall, to raise awareness of the tragedy
of firearm violence in our city. My wife and I participated, as did others from
Jefferson, Penn, Temple and Einstein. A public health approach to prevent
firearm-related injuries and deaths is much needed, and is underway. There
are data-driven studies being conducted and published on the topic. JCIRP is
involved and actively working on this topic. Our city is vibrant, diverse, historic,
and an exciting place to live. Five hundred victims are far too many.
To learn more about the Jefferson Center for Injury Research and Prevention,
please visit: Jefferson.edu/JCIRP

Meet the Interns
Last June, the following 16 categorical interns
began their training in our 3 General Surgery
Residency Programs.
Thomas Jefferson University Hospital

Abington – Jefferson Heatlh

Urooj Khalid, MD
Drexel University
College of Medicine

Subhadra Acharya, MD
Sidney Kimmel Medical College
at Thomas Jefferson University

Lindsay Edwards, MD
Chicago Medical School

Adam Scanlan, MD
Lewis Katz School of Medicine
at Temple University

Sneha Alaparthi, MD
Frank H. Netter School of Medicine
at Quinnipiac University

Isheeta Madeka, MD
Wake Forest School of Medicine

Nicholas Taylor, MD
Lewis Katz School of Medicine
at Temple University

Archana Babu, MD
Rutgers New Jersey
Medical School

Nayeem Nasher, MD
Georgetown University
School of Medicine
Wissam Nasser, MD
Rutgers New Jersey
Medical School

Jasmine Walker, MD
SUNY Downstate College
of Medicine

Christina Wohler, MD
Sidney Kimmel Medical College
at Thomas Jefferson University

Rowan University School of Osteopathic
Medicine & Jefferson Health System

Jason Barfuss, DO
Lake Erie College of
Osteopathic Medicine
Christopher Noty, DO
A.T. Still University of Health
Sciences Kirksville College of
Osteopathic Medicine

Liam Trimble, DO
William Carey University College of
Osteopathic Medicine
Camden Zemp, DO
Edward Via College of Osteopathic
Medicine - Virginia Campus
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Changing Lives Through Research

Four Faculty Members
Receive Grants, Awards
for Innovative Research
Congratulations to these Department
of Surgery faculty for receiving
significant grants to support
innovative research projects.
Jain awarded 2021 PanCAN Career
Development Award
In July, the Pancreatic
Cancer Action Network
named Aditi Jain, PhD,
one of seven recipients
of its 2021 Career
Development Award.
The two-year, $200,000 grant will
help Dr. Jain advance her project,
“Targeting BARD1 in Pancreatic Ductal
Adenocarcinoma.” In 2020, she was
appointed as Research Instructor at
the Jefferson Pancreas, Biliary and
Related Cancer Center, and newly
founded Pancreatic Cancer Research
Institute (PCRI).
Dr. Jain’s research involves
understanding the role of BARD1
(BRCA1-Associated Ring Domain 1)
in pancreatic cancer growth,
progression, and therapy resistance.
Her focus is targeting this protein
and potentially uncovering novel
therapeutic strategies.
To learn more about the
Jain Laboratory, visit:
Jefferson.edu/JainLab

Tchantchaleishvili honored with
translational research award
In July, the International
Society of Heart and
Lung Transplantation
awarded Vakhtang
Tchantchaleishvili,
MD, the lauded ISHLT/
O.H. Frazier Award in Mechanical
Circulatory Support (MCS) Translational
Research. The $65,000 grant supports
the project entitled “Impact of
Continuous-Flow Mechanical
Circulatory Support on Cerebrospinal
Fluid Motility” that he designed in
collaboration with Amy Throckmorton,
PhD, (on sabbatical from Drexel
University).
The team is investigating the impact
of blood pumps on the brain and
spinal fluid flow. With the funding,
Dr. Tchantchaleishvili’s team will
build an accurate model of the
cardiovascular system, brain, and
spinal fluid flow to better understand
conditions that arise while using a
blood pump and devise new treatment
solutions for patients with heart failure.
To learn more about the
Tchantchaleishvili laboratory, visit:
Jefferson.edu/VTLab

Miller recognized with
provost award
Okusanya named an inaugural
Earlier this year, Thomas
recipient in clinical trials diversity
Jefferson University
program
recognized Stanton B.
A review by the U.S. Food
Miller, MD, MPH, with a
& Drug Administration
Provost Award. Dr. Miller serves as
found that nearly 80
Executive Director of the Jefferson
percent of clinical trial
Center for Injury Research and
participants are white.
Prevention (JCIRP). This award
To address this lack of
supports the Center’s progress in
diversity, the Bristol Myers Squibb
the following major program areas:
Foundation, together with the National
geriatric injuries, firearm violence,
Medical Fellowships and the American
traffic injury, violence against the
Association for Cancer Research,
LGBTQ+ community, and suicide.
launched the Diversity in Clinical Trials
The award also enabled the
Career Development Program.
conversion of the Center’s physical
Thoracic surgeon Olugbenga T.
space on the 7th floor of the Curtis
Okusanya, MD, has been selected as a
Building into a modern state of the
recipient and awarded a two-year
art facility that will function as a
grant of $120,000 per year. He is one
Computer Science and Engineering
of 52 physicians from across the U.S.
Lab with the mission of scientific study
selected for the inaugural cohort of
and prevention of unintentional and
the five-year, $100 million initiative.
intentional societal injuries.
Through the program, Dr. Okusanya
To learn more about the Center, visit:
will be trained with additional
Jefferson.edu/JCIRP
knowledge, skills and competencies in
effective community outreach and
engagement.

Wound Healing Centers Offer
Specialized Expertise & Resources
The Wound Healing Centers of
Jefferson Health provide a focal point
for multidisciplinary evaluation and
treatment of patients with non-healing
wounds and those who have had or will
have a bowel or bladder ostomy surgery.
According to Regional Director Lisa
Hill, MSN, RN, CWOCN, the program
traces its roots to 1999, when Abington
Hospital created its first wound care
center. Today the Centers offer easily
accessible care at locations throughout
the Delaware Valley.
Care is delivered by medical and
nursing professionals specially trained
in evaluating wounds and ostomies
and recommending an individualized
treatment plan for each patient. The
team includes certified wound, ostomy
and continence nurses, certified wound
care nurses and physician specialists
trained in hyperbaric oxygen therapy.
Jefferson’s program has emerged as
a leader not only in patient care but
also in research related to wound care.
Clinicians have conducted research and
presented national data on the positive
impacts of hyperbaric oxygen therapy
on radiation tissue injury. Active studies
are exploring treatment of diabetic foot
wounds and interrelationships between
stroke and hyperbaric oxygen therapy.
The Wound Healing Centers attracted
national recognition for the treatment of
a cardiac catheterization patient with a
non-healing wound. As Hill explains, the
patient had been seeing a primary care
physician, who was unable to determine
why the wound was not healing.
“Our team figured out it was actually a
burn wound caused by radiofrequency

from her cardiac catheterization
procedure,” she recalls. “We were able to
treat the wound because we understood
the cause. For every patient we treat,
we perform a thorough assessment to
identify root causes and then establish
the course of treatment that will best
heal the wound.”
The centers offer a full complement
of outpatient services, including
hyperbaric oxygen therapy to treat
13 conditions (diabetic foot wounds,
radiation tissue injuries, osteomyelitis
and osteoradionecrosis are the most
common). Clinicians at the centers also
support a smooth continuum of care for
ostomy patients.
“When a patient is scheduled for a bowel
or bladder diversion, our team marks the
patient’s abdomen for the location of the
ostomy,” Hill says. “Following surgery,
we support post-operative healing
starting in the hospital and continuing
after the patient is discharged.”
Most insurance plans cover care by the
Wound Healing Centers of Jefferson
Health. To schedule an appointment,
call the most convenient location
(see below).
Scheduling an Appointment
Center City and
South Philadelphia – 215-955-7400
Lansdale and Warminster – 215-481-HEAL
Langhorne – 215-949-5030
North Philadelphia – 215-456-9604
Northeast Philadelphia – 267-587-9533
Plymouth Meeting – 484-622-7900
New Jersey: Cherry Hill &
Washington Township – 866-KHS-HEAL

For an appointment with a Jefferson Surgeon, call 1-800 -JEFF - NOW

Those Who Give

Finding a ‘Philanthropic Home’

W. Kim Foster

W. Kim Foster and Lisa Whitney met in the late
1970s as graduate business students at the
University of Virginia. In the decades that
followed, they explored the world and built a
life together. There was plenty of motion, with
frequent moves to new cities, trips around the
world (including five to Africa) and a shared
passion for scuba diving. There was also a
strong, steady foundation: their 40-year
marriage, Kim’s 34-year career with FMC
Corporation and, most importantly, daughter,
Amy, and sons, Will and Sam.

Nine months later, the family was participating
in the 11th Annual Pancreatic Cancer and
Related Diseases Patient Symposium at
Jefferson, where Kim spoke candidly about his
experience as a patient. A highly successful
businessman and former nuclear submariner in
the U.S. Navy, he was a natural leader and
problem solver. As Lisa recalls, “One of the
hardest things for him was accepting that he
could not manage or control it all himself. He
realized he had to put his faith in the intellect
and experience of the team at Jefferson.”

In February 2016, Kim and Lisa were four years
into one of their most exciting adventures –
retirement – when Kim developed jaundice.
After being referred to Charles J. Yeo, MD,
Samuel D. Gross Professor and Chair of
Surgery, Kim received a diagnosis of pancreatic
cancer. Within days, Dr. Yeo performed a miniWhipple procedure, which was followed by
radiation therapy with P. Rani Anné, MD, and
chemotherapy with James A. Posey, MD, and
Ashwin R. Sama, MD.

Despite that team’s valiant medical efforts, Lisa,
Amy, Will, and Sam said goodbye to Kim in
August 2018. In the face of this immeasurable
loss, Lisa has chosen to honor her husband by
recommending generous contributions to
Jefferson. The first gift established an endowed
research fund and named the W. Kim Foster
Pancreatic Cancer Collaborative Research
Space, which was dedicated in June 2019.
Lisa also directs annual gifts in support of the
W. Kim Foster Pancreatic Cancer Pilot Grants.

620 Curtis Building
1015 Walnut Street
Philadelphia, PA 19107

Lisa views the relationship with Jefferson as an
unexpected silver lining of everything she and
her children have been through: “Kim and I
often talked about giving back and longed to
find the place where the institutional goals
aligned with our family goals. The Foster family
has found a philanthropic home.”

To learn more about supporting cancer
research in the Department of Surgery,
contact Kelly Austin at 215-955-6383 or
kelly.austin@jefferson.edu.
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The program has already helped the 2020
inaugural recipient, radiation oncologist Adam
C. Mueller, MD, PhD, obtain additional funding
from the Radiological Society of North
America. Now in its second year, the program
continues to fund innovative research,
education, and programs related to pancreatic
cancer. [See News in Brief for 2021 recipients.]
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News in Brief
In July, Scott D. Goldstein, MD, retired
following 37 years as a faculty member in the
Division of Colorectal Surgery –
 including
over 17 years as division chief. We thank him
for the decades of clinical excellence, patient
care, teaching, and leadership he provided our patients,
trainees, faculty and staff.
Benjamin R. Phillips, MD, has been named
Chief of the Division of Colorectal Surgery
following a national search. Dr. Phillips is a
graduate of our Colorectal Fellowship Program
and joined the faculty in 2013. He has received
numerous teaching awards, including the Dean’s Award
for Excellence in Education, and is a Past President of the
Pennsylvania Society of Colon and Rectal Surgeons.

Alliric Willis, MD, MSPH, has been named
Associate Dean for Faculty Affairs. He also
recently completed his Master of Science in
Population Health (MSPH) degree.
On November 13, Steven Copit, MD,
Enterprise Chief of Plastic Surgery, was
honored with the Founders Award from Living
Beyond Breast Cancer at the Butterfly Ball
held at the Loews Philadelphia Hotel.
Joshua Marks, MD and George
Koenig, DO, (Division of Acute
Care Surgery) have been named
Medical Co-Directors of the
Center for Operational Resource
Efficiency (CORE) and the Transfer Center.
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In November, 2 W. Kim Foster Pilot Grants were
awarded to (1) Avinoam Nevler, MD for his
work entitled “Targeting CO2 chemoresistance
and radioresistance in pancreatic ductal
adenocarcinoma” and (2) Shawnna Cannaday,
MSN, FNP-BC, and Theresa P. Yeo, PhD,
MPH, for their project entitled “Implementing
Educational Videos to Enhance Preparedness
for Surgery.” For background on this grant
program, see Those Who Give.

